Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Cancer Screening
Genetic cancer test stirs debate
July 4th, 2002
The contentious debate over aggressive marketing of prescription drugs and other pharmaceutical products is about to get a new twist. Myriad Genetics, Inc., which makes tests for genetic predisposition to certain kinds of cancers, is starting a big marketing push with doctors this summer. In the fall, it will launch a direct-advertising campaign aimed at women to promote the test for breast and ovarian cancers. As in other ads for prescribed products, viewers are urged to consult their doctors. But these ads apparently are the first of their kind to promote genetic testing directly to the public and a part of a controversial marketing effort to...
Source: Women's Health Weekly (2002-07-04)
|
